The Effects of Lemon Essential Oil Inhalation on Attention in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Lemon Essential Oil Inhalation Improves Sustained Attention in Children With Attention-Deficit/Hyperactivity Disorder: A Placebo-Controlled Trial
調査の概要
状態
詳細な説明
This randomized, placebo-controlled, single-blind clinical trial investigates the acute effects of lemon essential oil (LEO) inhalation on sustained attention and visual memory in children with attention-deficit/hyperactivity disorder (ADHD). Essential oils, particularly those rich in monoterpenes such as limonene, have demonstrated neuroactive properties through cholinergic modulation and limbic-prefrontal engagement via the olfactory pathway.
Fifty-two children aged 9-16 years, newly diagnosed with ADHD and not receiving any pharmacological treatment, were randomized to either the LEO group or the placebo group. Participants in the LEO group inhaled 5 drops of 100% pure Citrus limon essential oil via a cotton pad for five minutes prior to cognitive testing. The placebo group received an identical application with odorless distilled water.
Cognitive performance was assessed at baseline and 30 days later using the D2 Attention Test (primary outcome) and the Benton Visual Memory Test (secondary outcome). The entire intervention was conducted under standardized conditions, with blinded outcome assessment and strict adherence to procedural fidelity.
This study is the first to evaluate the short-term cognitive effects of lemon essential oil inhalation in children with clinical ADHD and aims to provide evidence for potential non-pharmacological support strategies.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Istanbul、トルコ(Türkiye)
- Basaksehir Çam Ve Sakura City Hospital
-
-
参加基準
適格基準
就学可能な年齢
- 子
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Children aged 9 to 16 years
- Diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) based on DSM-5 criteria
- Medication-naive (not currently using or previously treated with pharmacological agents for ADHD)
- No chronic medical or psychiatric comorbidities
- Capable of completing standardized cognitive assessments (e.g., D2 Attention Test, Benton Visual Memory Test)
- Written informed consent obtained from a parent or legal guardian
- Written assent obtained from the child
Exclusion Criteria:
- Lack of written parental consent or child assent
- Inability to comply with the study protocol (e.g., refusal to complete cognitive testing or intervention procedure)
- Current or prior use of ADHD medication
- Presence of moderate-to-severe ADHD symptoms requiring immediate pharmacological treatment (based on AACAP 2020 and NICE 2019 guidelines)
- Presence of any chronic medical or psychiatric comorbid condition
- Diagnosis not confirmed by a board-certified child and adolescent psychiatrist
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:支持療法
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Lemon Essential Oil Inhalation (LEO)
Participants in this arm received a single-session inhalation of 100% pure lemon essential oil (Citrus limon) via a sterile cotton pad.
Five drops of essential oil were applied to the pad, which was held approximately 5 cm from the participant's nose.
The child inhaled the scent for 5 minutes under supervision in a clinical setting.
Neuropsychological testing (D2 Attention Test and Benton Visual Memory Test) followed immediately after inhalation.
|
This intervention consists of a single-session, short-term olfactory exposure to 100% pure lemon essential oil (Citrus limon, ISO 9235 compliant, GC-MS confirmed composition: limonene 67.2%, β-pinene 12.3%, γ-terpinene 9.8%).
Five drops were applied to a sterile cotton pad and held approximately 5 cm from the participant's nose.
Participants inhaled the aroma for 5 minutes under direct supervision in a quiet, odor-free clinical setting.
This intervention was administered immediately prior to standardized neuropsychological assessments measuring attention and visual memory.
No ingestion or topical application occurred.
他の名前:
|
|
プラセボコンパレーター:Placebo Inhalation (Distilled Water)
Participants in this arm received a single-session inhalation of distilled water as placebo.
Five drops of distilled water were applied to a sterile cotton pad, which was held approximately 5 cm from the participant's nose.
The child inhaled the scentless solution for 5 minutes under supervision.
Neuropsychological testing (D2 Attention Test and Benton Visual Memory Test) followed immediately after inhalation.
|
The placebo condition involved the same protocol as the intervention group, using five drops of distilled water applied to a sterile cotton pad.
The pad was held approximately 5 cm from the participant's nose, and inhalation lasted for 5 minutes.
The procedure was designed to mimic the intervention without olfactory stimulation, ensuring consistency in timing, setting, and administration method.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in D2 Attention Test Total Performance Score (TN-E)
時間枠:Baseline and Day 30 (after intervention)
|
The D2 Attention Test evaluates sustained attention and concentration performance.
The TN-E (Total Number of Correct Items minus Errors) score reflects attentional capacity.
A higher post-intervention TN-E score indicates improved attention.
The difference between baseline and Day 30 scores will be compared between the lemon essential oil group and placebo group.
|
Baseline and Day 30 (after intervention)
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in Benton Visual Retention Test (BVRT) Score
時間枠:Baseline and Day 30 (after intervention)
|
The Benton Visual Retention Test assesses visual memory and visuospatial construction skills.
Scores range based on correct reproductions of geometric figures.
The change in BVRT scores from baseline to Day 30 will be analyzed to assess the impact of lemon essential oil inhalation versus placebo.
|
Baseline and Day 30 (after intervention)
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
追加の関連 MeSH 用語
その他の研究ID番号
- 10.06.2021-21
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。